Compare Edelweiss Technology Fund vs HDFC Mid Cap Fund
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | - | ₹100 |
Expense Ratio | 0.16 | 1.36 |
NAV | ₹58.31 | ₹197.39 |
Fund Started | 08 Feb 2024 | 07 May 2007 |
Fund Size | ₹642.81 Cr | ₹92641.55 Cr |
Exit Load | - | Exit load of 1% if redeemed within 1 year. |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
-
₹100
Expense Ratio
0.16
1.36
NAV
₹58.31
₹197.39
Fund Started
08 Feb 2024
07 May 2007
Fund Size
₹642.81 Cr
₹92641.55 Cr
Exit Load
-
Exit load of 1% if redeemed within 1 year.
1 Year | 5.76% | 9.19% |
3 Year | - | 24.69% |
5 Year | - | 23.80% |
1 Year
5.76%
9.19%
3 Year
-
24.69%
5 Year
-
23.80%
Equity | 99.81% | 92.88% |
Cash | 0.19% | 7.12% |
Equity
99.81%
92.88%
Cash
0.19%
7.12%
Top 10 Holdings |
|
|
Top 10 Holdings
BSE Ltd. | 3.39% |
Hero Motocorp Ltd. | 2.36% |
Persistent Systems Ltd. | 2.15% |
The Federal Bank Ltd. | 2.07% |
Suzlon Energy Ltd. | 2.02% |
PB Fintech Ltd. | 1.96% |
Cummins India Ltd. | 1.89% |
Indusind Bank Ltd. | 1.80% |
AU Small Finance Bank Ltd. | 1.77% |
IDFC First Bank Ltd. | 1.77% |
Max Financial Services Ltd. | 4.65% |
AU Small Finance Bank Ltd. | 4.21% |
The Federal Bank Ltd. | 3.69% |
Indian Bank | 3.33% |
Balkrishna Industries Ltd. | 3.31% |
Hindustan Petroleum Corporation Ltd. | 2.99% |
Coforge Ltd. | 2.80% |
Glenmark Pharmaceuticals Ltd. | 2.78% |
Ipca Laboratories Ltd. | 2.74% |
Mahindra & Mahindra Financial Services Ltd. | 2.70% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to provide returns that correspond to the total returns of securities as represented by Nifty Midcap 100 Total Return Index, subject to tracking errors. | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. |
Launch Date | 08 Feb 2024 | 07 May 2007 |
Description
The scheme seeks to provide returns that correspond to the total returns of securities as represented by Nifty Midcap 100 Total Return Index, subject to tracking errors.
The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies.
Launch Date
08 Feb 2024
07 May 2007